These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of acupoint-catgut-embedment on mammary gland hyperplasia].
    Author: Zhou L, Lu X, Feng ZG, Shen XX, Wu JQ.
    Journal: Zhen Ci Yan Jiu; 2011 Feb; 36(1):52-6. PubMed ID: 21585060.
    Abstract:
    OBJECTIVE: To evaluate the clinical therapeutic effect of acupoint-catgut-embedment therapy in the treatment of mammary gland hyperplasia (MGH). METHODS: Eighty MGH patients were equally randomized into acupoint-catgut-embedment (ACE) group and medication (Rupixiao, a herbal patent drug for relieving MGH) group according to odd-numbered days or even-numbered days of visiting. Subcutaneous catgut-embedment was performed in Wuyi (ST 15), Rugen (ST 18), Tanzhong (CV 17), Xuehai (SP 10), Zusanli (ST 36) and Yanglingquan (GB 34), once every 15 days for 3 months. Patients of the medication group were treated by oral administration of Rupixiao (3 tablets, 3 times per day, 3 months altogether). The degree of breast pain and the size of the hyperplastic lump were observed before and after the treatment. Serum estrodiol, progesterone and prolactin contents on day 1 to day 3 of menstruation were detected by using an automation chemiluminescence immune analysator. RESULTS: After the treatment, of the two 40 MGH patients in the ACE and medication groups, 16 (40. 0%) and 5 (12. 5%) were cured basically, 8 (20. 0%) and 8 were improved markedly in their symptoms and signs, 16 (40. 0%) and 22 (55. 0%) were effective, and 0 and 5 (12. 5%) failed in the treatment, with the effective rates being 100% and 87.5%, respectively. The therapeutic effect of the ACE group was significantly better than that of the medication group (P<0. 05). In comparison with the pretreatment, the pain grades and the size of the hyperplastic lump in both ACE and medication groups decreased significantly after immediate termination of the treatment and 6 months after the treatment (P<0.01), and the therapeutic effects of the ACE group were significantly superior to those of the medication group in reducing pain grade and hyperplastic lump size (P<0. 01). After the treatment, serum estrodiol and progesterone contents were decreased evidently in both ACE and medication groups (P<0. 01, P<0. 05). Type-B ultrasonic examination showed that of the two 40 MGH patients in the ACE and medication groups, 16 and 5 cases turned to normal in their mammary glands, and the cure rate of the ACE group was evidently higher than that of the medication group (P<0. 01). CONCLUSION: Acupoint-catgut-embedment is effective in relieving MGH, and its therapeutic effect is apparently superior to that of medication (oral administration of Rupixiao).
    [Abstract] [Full Text] [Related] [New Search]